MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Clinical trial NCT06712875 · RECRUITING
Trial details
- NCT number
- NCT06712875
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2028-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.